/PRNewswire/ Stämm, a biotechnology company developing an innovative biomanufacturing platform of continuous and autonomous production at an industrial.
/PRNewswire/ Stämm, a biotechnology company developing an innovative biomanufacturing platform of continuous and autonomous production at an industrial.
/PRNewswire/ Stämm, an early-stage biotechnology company based in Buenos Aires, recently announced raising $17 million in its Series A round. The round was.
/PRNewswire/ Stämm, an early-stage biotechnology company based in Buenos Aires, recently announced raising $17 million in its Series A round. The round was.